Sistema de Salut de Catalunya
[Not A, Martró E] Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Servei de Microbiologia, Laboratori Clínic de la Metropolitana Nord (LCMN), Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Spain. Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. [Ouaarab-Essadek H, Treviño B, Gómez i Prat J] Equip de Salut Pública i Comunitària (eSPIc), Unitat de Salut Internacional Drassanes-Vall d’Hebron, Barcelona, Spain. [Montoro M] Centre d'Estudis Epidemiològics Sobre les ITS i la Sida de Catalunya (CEEISCAT), Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Spain. [Buti M] Servei d’Hepatologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Consorcio de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. [Morillas RM] Consorcio de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain. Unitat d’Hepatologia, Departament Digestiu, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. [Bordoy AE] Servei de Microbiologia, Laboratori Clínic de la Metropolitana Nord (LCMN), Institut de Recerca Germans Trias i Pujol (IGTP), Badalona, Spain. [Folch C, Casabona J] Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain. Centre d'Estudis Epidemiològics Sobre les ITS i la Sida de Catalunya (CEEISCAT), Agència de Salut Pública de Catalunya (ASPCAT), Barcelona, Spain. [Majó X] Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain
Departament de Salut
2025-06-06T09:10:49Z
2025-06-06T09:10:49Z
2025-06
Community action; Dried blood spots (DBS); Hepatitis B virus (HBV); Hepatitis C virus (HCV)
Acción comunitaria; Gotas de sangre seca (GDS); Virus de la hepatitis B (VHB); Virus de la hepatitis C (VHC)
Acció comunitària; Gotes de sang seca (GDS); Virus de l'hepatitis B (VHB); Virus de l'hepatitis C (VHC)
Migrants from endemic areas are key populations for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection screening in Europe. This study assessed the feasibility and outcomes of a community action that combined education, screening, and simplified access to care for migrants in Barcelona. Adult migrants from Pakistan, Romania, and Senegal were included from 2021 to 2023, through a community action involving education, an epidemiological questionnaire, and rapid testing for HBV surface antigen (HBsAg) and HCV antibodies. If positive, DBS samples were collected for laboratory confirmation. Viremic cases were referred to an International Health Unit (IHU). Overall, 786 participants were included (346 from Pakistan, 304 from Senegal and 136 from Romania). Previous screening for HBV and HCV was 8.0% and 7.7%, respectively. HBsAg prevalence was 0.9% for migrants from Pakistan, 8.2% for those from Senegal and 1.4% for those from Romania (n = 30/786, 23 new diagnoses). Among these, 69.6% attended the IHU and were HBV-DNA positive, but none met treatment criteria. Anti-HCV prevalence was 3.5%, 0.7% and 1.4% for migrants from Pakistan, Senegal and Romania, respectively (n = 16/768, 12 new diagnoses), and HCV-RNA prevalence was 0.9%, 0.3% and 0.7%, respectively (N = 6, all new diagnoses); 4 (66.6%) cases were linked to treatment and two were cured. This novel community action successfully reached migrants in a situation of vulnerability and provided them access to testing and care. The high prevalence observed and the limited self-knowledge of their HBV and HCV status justify targeted screening in these groups.
Article
Published version
English
Hepatitis B; Hepatitis C; Cribatge (Medicina); Riscos per a la salut - Avaluació; Serveis comunitaris de salut; Immigrants - Barcelona; DISEASES::Virus Diseases::DNA Virus Infections::Hepadnaviridae Infections::Hepatitis B; DISEASES::Virus Diseases::Hepatitis, Viral, Human::Hepatitis C; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Mass Screening; HEALTH CARE::Health Services Administration::Patient Care Management::Delivery of Health Care::Health Services Accessibility; Barcelona; ENFERMEDADES::virosis::infecciones por virus ADN::infecciones por Hepadnaviridae::hepatitis B; ENFERMEDADES::virosis::hepatitis viral humana::hepatitis C; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::cribado sistemático; ATENCIÓN DE SALUD::administración de los servicios de salud::gestión de la atención al paciente::prestación sanitaria::accesibilidad a los servicios de salud; Barcelona
Wiley Online Library
Liver international;45(6)
https://www.doi.org/10.1111/liv.70126
Attribution-NonCommercial 4.0 International
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3393]
